Suppressed bone turnover in obesity: a link to energy metabolism? A case-control study.

CONTEXT Observations in rodents suggest that osteocalcin (OC) participates in glucose metabolism. Based on human studies, it remains unclear whether circulating OC is simply a bone turnover marker (BTM) or also a mediator in interactions between the skeleton and glucose homeostasis. OBJECTIVE The objective of the study was to determine the responses of BTMs, including OC, to oral glucose tolerance test (OGTT) in a case-control setting. DESIGN AND PATIENTS Thirty-four normoglycemic young adults [mean age 19 y (SD 2.3)] with severe childhood-onset obesity and their gender- and age-matched nonobese controls underwent a standard 2-hour OGTT. MAIN OUTCOME MEASURES Glucose, insulin, and six BTMs including total and carboxylated OC (cOC) were determined at baseline and at 30, 60, 90, and 120 minutes during OGTT. RESULTS The obese and control subjects were similar in height; the mean body mass indices were 40.4 and 21.9 kg/m(2), respectively. The homeostasis model assessment index was 2.7 times greater in the obese subjects. All BTMs, except bone-specific alkaline phophatase, were lower in the obese subjects compared with the controls: the differences at baseline were 40%, 35%, 17%, 31%, and 32% for N-terminal propeptides of type I collagen, cross-linked telopeptides of type I collagen, tartrate-resistant acid phosphatase, total OC, and carboxylated OC (P < .05 for all) after adjusting for whole-body bone area. All BTMs decreased during OGTT. The relative values for the OGTT responses for total, but not for cOC (measured as area under the curve) differed between the two groups (P = .029 and P = .139, respectively): the decrease in total OC during the OGTT was less pronounced in the obese subjects. Responses in other BTMs were similar between the groups. No associations were observed between glucose metabolism and OCs during OGTT with linear regression. CONCLUSIONS Bone turnover markers were substantially lower in obese subjects compared with controls. Total OC and cOC showed less pronounced decrease during the OGTT in obese subjects compared with controls, whereas other BTMs responded similarly in the two groups. The role of OC, if anything, in glucose homeostasis is indirect and may be mediated via other factors than glucose or insulin.

[1]  R. Lindsay,et al.  Determinants of stress fracture risk in United States Military Academy cadets. , 2013, Bone.

[2]  S. Cummings,et al.  Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  O. Mäkitie,et al.  Total and Carboxylated Osteocalcin Associate with Insulin Levels in Young Adults Born with Normal or Very Low Birth Weight , 2013, PloS one.

[4]  C. Koebnick,et al.  Childhood Obesity Is Associated With Increased Risk of Most Lower Extremity Fractures , 2013, Clinical orthopaedics and related research.

[5]  Binsheng Zhao,et al.  Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. , 2013, The Journal of clinical endocrinology and metabolism.

[6]  R. Baron,et al.  What are the effects of leptin on bone and where are they exerted? , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Martínez,et al.  Young overweight and obese women with lower circulating osteocalcin concentrations exhibit higher insulin resistance and concentrations of C-reactive protein. , 2013, Nutrition research.

[8]  S. Booth,et al.  The role of osteocalcin in human glucose metabolism: marker or mediator? , 2013, Nature Reviews Endocrinology.

[9]  Z. Şıklar,et al.  Relationships Between Osteocalcin, Glucose Metabolism, and Adiponectin in Obese Children: Is there Crosstalk Between Bone Tissue and Glucose Metabolism? , 2012, Journal of clinical research in pediatric endocrinology.

[10]  F. Gallé,et al.  Prevalence of overweight in children with bone fractures: a case control study , 2012, BMC Pediatrics.

[11]  T. Törmäkangas,et al.  Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. , 2012, The Journal of clinical endocrinology and metabolism.

[12]  M. Brandi,et al.  Bone mass regulation of leptin and postmenopausal osteoporosis with obesity. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[13]  J. Lian,et al.  Vitamin K-dependent carboxylation of osteocalcin: friend or foe? , 2012, Advances in nutrition.

[14]  R. Considine,et al.  Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  M. McKee,et al.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. , 2012, Bone.

[16]  R. Eastell,et al.  Obesity is a risk factor for fracture in children but is protective against fracture in adults: a paradox. , 2012, Bone.

[17]  L. Hofbauer,et al.  Bone, sweet bone—osteoporotic fractures in diabetes mellitus , 2012, Nature Reviews Endocrinology.

[18]  O. Mäkitie,et al.  The Effect of Oral Glucose Tolerance Test on Serum Osteocalcin and Bone Turnover Markers in Young Adults , 2011, Calcified Tissue International.

[19]  M. Gagner,et al.  Increased PTH and 1.25(OH)2D Levels Associated With Increased Markers of Bone Turnover Following Bariatric Surgery , 2011, Obesity.

[20]  Y. Hwang,et al.  Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level , 2011, Osteoporosis International.

[21]  T. Clemens,et al.  The osteoblast: An insulin target cell controlling glucose homeostasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  N. Bishop,et al.  Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. , 2011, Bone.

[23]  P. Ducy,et al.  Co-dependence of bone and energy metabolisms. , 2010, Archives of biochemistry and biophysics.

[24]  K. Hind,et al.  In vivo precision of the GE Lunar iDXA densitometer for the measurement of total-body, lumbar spine, and femoral bone mineral density in adults. , 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[25]  R. DePinho,et al.  Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism , 2010, Cell.

[26]  Chao Wan,et al.  Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition , 2010, Cell.

[27]  P. Gerdhem,et al.  Bone turnover markers and prediction of fracture: A prospective follow‐up study of 1040 elderly women for a mean of 9 years , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  J. Holst,et al.  Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD. , 2009, Bone.

[29]  S. Booth,et al.  Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. , 2009, The American journal of clinical nutrition.

[30]  T. Martin,et al.  Bone as an endocrine organ , 2009, Trends in Endocrinology & Metabolism.

[31]  D. Mellström,et al.  Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  B. Dawson-Hughes,et al.  Association between serum osteocalcin and markers of metabolic phenotype. , 2009, The Journal of clinical endocrinology and metabolism.

[33]  R. Bouillon,et al.  Bone and Metabolism: A Complex Crosstalk , 2009, Hormone Research in Paediatrics.

[34]  K. Kaestner,et al.  The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity , 2008, The Journal of cell biology.

[35]  G. Karsenty,et al.  Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice , 2008, Proceedings of the National Academy of Sciences.

[36]  J. Rissanen,et al.  Secreted Tartrate-Resistant Acid Phosphatase 5b is a Marker of Osteoclast Number in Human Osteoclast Cultures and the Rat Ovariectomy Model , 2008, Calcified Tissue International.

[37]  Walter C Willett,et al.  Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. , 2007, American journal of epidemiology.

[38]  M. McKee,et al.  Endocrine Regulation of Energy Metabolism by the Skeleton , 2007, Cell.

[39]  P. Gerdhem,et al.  Prediction of bone loss using biochemical markers of bone turnover , 2007, Osteoporosis International.

[40]  J. Holst,et al.  Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. , 2007, Bone.

[41]  Mary L Bouxsein,et al.  Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.

[42]  D. Balzi,et al.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. , 2005, American journal of physiology. Endocrinology and metabolism.

[43]  R. Eastell,et al.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption , 1993, Osteoporosis International.

[44]  M. Econs,et al.  Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). , 2004, Clinical chemistry.

[45]  V. Bini,et al.  Relationships of Serum Leptin Levels with Biochemical Markers of Bone Turnover and with Growth Factors in Normal Weight and Overweight Children , 2004, Hormone Research in Paediatrics.

[46]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[47]  J. Holst,et al.  Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. , 2004, Bone.

[48]  Quyen Q. Hoang,et al.  Bone recognition mechanism of porcine osteocalcin from crystal structure , 2003, Nature.

[49]  R. Eastell,et al.  Octreotide abolishes the acute decrease in bone turnover in response to oral glucose. , 2003, The Journal of clinical endocrinology and metabolism.

[50]  W. Tamborlane,et al.  Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. , 2002, The New England journal of medicine.

[51]  R. Walker,et al.  Diagnosing insulin resistance in the general population. , 2001, Diabetes care.

[52]  M. Karp,et al.  Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. , 2000, Clinical chemistry.

[53]  C. Mølgaard,et al.  Whole body bone mineral accretion in healthy children and adolescents , 1999, Archives of disease in childhood.

[54]  Sheila M. Williams,et al.  Bone Mineral Density in Girls with Forearm Fractures , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.